A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis

Authors

Gloria Roldan Urgoiti
Paula de Robles
Roger Y Tsang
Morgan Willson
Sunita Ghosh, Henry Ford HealthFollow
Muhammad Faruqi
Gerald Lim
Shaun Loewen
Robert Nordal
Gregory Cairncross
Catriona Leckie
Candice C Poon
V Wee Yong

Recommended Citation

Roldan Urgoiti G, de Robles P, Tsang RY, Willson M, Ghosh S, Faruqi M, Lim G, Loewen S, Nordal R, Cairncross G, Leckie C, Poon CC, and Yong VW. A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis. J Neurooncol 2025;176(1):101.

Document Type

Article

Publication Date

11-28-2025

Publication Title

Journal of neuro-oncology

Keywords

Glioblastoma; Immunotherapy; Niacin; Phase I-II

PubMed ID

41313494

Volume

176

Issue

1

First Page

101

Last Page

101